Teva Pharmaceutical Industries Ltd Adr (TEVA)

03:02 AM

Target Upgraded, Robinhood Downgraded: Updated Rankings on Top Blue-Chip Stocks - investorplace.com

03:02 AM

Apr 05, 2026

How Investors Are Reacting To Teva (TEVA) Advancing Its Biosimilar Pipeline With New FDA and EMA Milestones - Sahm

Apr 05, 2026

Apr 03, 2026

Assessing Teva Pharmaceutical Industries (TEVA) Valuation After New Biosimilar Approvals And Pipeline Progress - Sahm

Apr 03, 2026

Apr 02, 2026

Viatris at $14: A Double-Digit FCF Yield Hiding in Plain Sight - Investing.com

Apr 02, 2026

Apr 02, 2026

Missile Strike Tests Teva Supply Resilience And Biosimilar Growth Plans - Sahm

Apr 02, 2026

Apr 01, 2026

Price to sales ratio of Teva Pharmaceutical Industries Limited Sponsored ADR – BSESOF:TEV - TradingView

Apr 01, 2026

Mar 30, 2026

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) - Sahm

Mar 30, 2026

Mar 27, 2026

ETFs Investing in Teva Pharmaceutical Industries Limited Sponsored ADR Stocks - TradingView

Mar 27, 2026

Mar 25, 2026

How Investors May Respond To Teva (TEVA) Advancing TEV ‘325 In Biologics For Inflammatory Diseases - Sahm

Mar 25, 2026

Mar 24, 2026

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Recent Share Price Weakness - Sahm

Mar 24, 2026

Mar 20, 2026

TEVA Stock Price, Quote & Chart | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill

Mar 20, 2026

Mar 19, 2026

Teva Pharmaceutical Industries Limited Sponsored ADR Trade Ideas — LS:883035 - TradingView

Mar 19, 2026

Mar 19, 2026

Teva Releases Q1 2026 Aide Memoire - Sahm

Mar 19, 2026

Mar 18, 2026

Will Teva’s (TEVA) Olanzapine LAI Milestone and Legal Win Change Its Innovation-Led Narrative? - Sahm

Mar 18, 2026

Mar 17, 2026

Tesla Upgraded, Super Micro Computer Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Mar 17, 2026

Mar 11, 2026

How Teva’s Blackstone-Backed ‘Pivot to Growth’ Strategy Could Reshape Teva Pharmaceutical Industries (TEVA) Investors - Sahm

Mar 11, 2026

Mar 10, 2026

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Pivot To Growth Update At Leerink Conference - Sahm

Mar 10, 2026

Mar 06, 2026

Teva Blackstone Duvakitug Deal Tests Growth Story And Concentration Risk - Sahm

Mar 06, 2026

Mar 03, 2026

Teva Drug Updates Support Branded Growth Story And Valuation Upside Potential - Sahm

Mar 03, 2026

Mar 02, 2026

What's Driving the Market Sentiment Around Teva Pharmaceutical Industries Ltd? - Sahm

Mar 02, 2026

Mar 01, 2026

Duvakitug IBD Data and TEV-749 Filing Might Change The Case For Investing In Teva (TEVA) - Sahm

Mar 01, 2026

Feb 28, 2026

Teva to Present at the Upcoming Investor Conferences in March - Sahm

Feb 28, 2026

Feb 27, 2026

J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? - Finviz

Feb 27, 2026

Feb 26, 2026

Where is Teva Pharmaceutical Industries Limited (TEVA) Headed? - Finviz

Feb 26, 2026

Feb 25, 2026

Corcept's Q4 Earnings and Revenues Fall Short of Estimates - Finviz

Feb 25, 2026

Feb 23, 2026

FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application - Sahm

Feb 23, 2026

Feb 22, 2026

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Its Strong Recent Share Price Momentum - Sahm

Feb 22, 2026

Feb 20, 2026

Truist Boosts Teva (TEVA) Stock Target Amid Pipeline Growth Opportunities - Finviz

Feb 20, 2026

Feb 19, 2026

Corcept Therapeutics Stock Plunges As Court Clears Teva Generic - Sahm

Feb 19, 2026

Feb 18, 2026

Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026 - Finviz

Feb 18, 2026

Feb 18, 2026

Teva Pharmaceutical Industries Ltd (TEVA) Stock Price, Trades & News - GuruFocus

Feb 18, 2026

Feb 18, 2026

Teva’s Duvakitug Data Puts Ulcerative Colitis And Crohn’s Bet In Focus - Sahm

Feb 18, 2026

Feb 17, 2026

Should You Invest in Teva Pharmaceutical (TEVA), Here's What the Street Has to Say - Finviz

Feb 17, 2026

Feb 12, 2026

Teva (TEVA) Is Down 5.2% After Returning To Profitability On Innovation-Led Revenue Shift – What’s Changed - Sahm

Feb 12, 2026

Feb 10, 2026

Teva Pharmaceutical Industries (NYSE:TEVA) Valuation In Focus Amid Momentum - Kalkine Media

Feb 10, 2026

Feb 10, 2026

Here's What Analysts Are Saying About Teva Pharmaceutical (TEVA) Post Earnings - Finviz

Feb 10, 2026

Feb 10, 2026

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Recent Share Price Momentum And Biosimilar Growth Hopes - Sahm

Feb 10, 2026

Feb 09, 2026

A Look Into Teva Pharmaceutical Indus Inc's Price Over Earnings - Sahm

Feb 09, 2026

Feb 04, 2026

Barclays Raises Teva Pharmaceutical (TEVA) PT to $38 Following Strong Q4 Earnings Beat - Finviz

Feb 04, 2026

Feb 04, 2026

Teva Canada Announces Approval of Expanded Indication of [Pr]AJOVY® (fremanezumab solution for subcutaneous injection), the First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine - Sahm

Feb 04, 2026

Feb 04, 2026

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory - Finviz

Feb 04, 2026

Feb 03, 2026

Teva Canada Mayzent Deal Supports Neuroscience Focus And Valuation Debate - Sahm

Feb 03, 2026

Feb 03, 2026

FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Feb 03, 2026

Feb 03, 2026

Earnings call transcript: Teva Q4 2025 earnings beat expectations, stock rises - Investing.com

Feb 03, 2026

Feb 02, 2026

Assessing Teva Pharmaceutical Industries’ Valuation After Strong 2025 Earnings And Analyst Upgrades - Sahm

Feb 02, 2026